An effort to diversify genetic studies has led to a discovery about Parkinson's disease in people of African descent.
Diseases like Alzheimer's and Parkinson's spread through the brain like a forest fire. A new study suggests how the fire starts.
Arts therapies appear to ease brain disorders from Parkinson's to PTSD. Now, artists and scientists have launched an effort to understand how these treatments change the brain.
The symptoms of Parkinson's disease can vanish briefly in the face of stress or a strong emotion. Now scientists are searching for a treatment based on this phenomenon, a form of the placebo effect.
A leukemia drug seemed to help patients with Parkinson's disease. But critics say the results are equivocal and could raise false hopes.
The pharmaceutical giant said it would be abandoning its neuroscience development programs and allocating its spending elsewhere. The move also means the company will lay off some 300 employees.
In 2003, researchers declared a moratorium on the use of transplanted brain cells to treat Parkinson's disease. Now, armed with better cells, they're giving the approach another try.
The company 23andMe is now allowed to market tests that assess genetic risks for 10 health conditions, including Parkinson's and late-onset Alzheimer's diseases.